photo of

Details

Role Team Leader / Dir. Cord Blood Bank
Research area Stem Cell Medicine

Contact

Available for student supervision
Associate Professor Ngaire Elwood is the Director of the BMDI Cord Blood Bank and Head of the Cord Blood Stem Cell Research Laboratory at the Murdoch Children's Research Institute. Her current research interest is aimed at extending the use of cord blood for cellular therapies, particularly through clinical grade cord blood derived iPSCs and cord blood for cardiac repair..

Ngaire serves as Chair of the AusCord network of public cord blood banks. She is Vice President of the international Board of Directors for the Foundation for the Accreditation of Cellular Therapies (FACT), is a FACT inspector and serves on various FACT committees. Other board and executive appointments include Non-Executive Director on the Board of the National Stem Cell Foundation of Australia, Chair of the Australian Sickle Cell Advocacy Inc, and a member of the Board of the International Society for Cell & Gene Therapy (ISCT). Ngaire serves on the TGA Advisory Committee on Biologicals and the MCRI Institutional Biosafety Committee.

Ngaire has devoted her career to providing improved therapies for the treatment of cancer, leukaemia and other disorders, and is passionate about the therapeutic application of cellular therapies.
Associate Professor Ngaire Elwood is the Director of the BMDI Cord Blood Bank and Head of the Cord Blood Stem Cell Research Laboratory at the Murdoch Children's Research Institute. Her current research interest is aimed at extending the use of cord...
Associate Professor Ngaire Elwood is the Director of the BMDI Cord Blood Bank and Head of the Cord Blood Stem Cell Research Laboratory at the Murdoch Children's Research Institute. Her current research interest is aimed at extending the use of cord blood for cellular therapies, particularly through clinical grade cord blood derived iPSCs and cord blood for cardiac repair..

Ngaire serves as Chair of the AusCord network of public cord blood banks. She is Vice President of the international Board of Directors for the Foundation for the Accreditation of Cellular Therapies (FACT), is a FACT inspector and serves on various FACT committees. Other board and executive appointments include Non-Executive Director on the Board of the National Stem Cell Foundation of Australia, Chair of the Australian Sickle Cell Advocacy Inc, and a member of the Board of the International Society for Cell & Gene Therapy (ISCT). Ngaire serves on the TGA Advisory Committee on Biologicals and the MCRI Institutional Biosafety Committee.

Ngaire has devoted her career to providing improved therapies for the treatment of cancer, leukaemia and other disorders, and is passionate about the therapeutic application of cellular therapies.

Top Publications

  • Abberton, KM, McDonald, TL, Diviney, M, Holdsworth, R, Leslie, S, Delatycki, MB, Liu, L, Klamer, G, Johnson, P, Elwood, NJ. Identification and Re-consent of Existing Cord Blood Donors for Creation of Induced Pluripotent Stem Cell Lines for Potential Clinical Applications.. Stem Cells Transl Med 11(10) : 1052 -1060 2022
    view publication
  • Klamer, G, Sue, J, Trickett, A, Ko, K-H, Johnson, P, Elwood, NJ. A comprehensive human leukocyte antigen analysis of 36 782 cord blood units stored in the Australian Public Cord Blood Banking Network.. Cytotherapy 24(10) : 990 -998 2022
    view publication
  • Klamer, G, Sue, J, Ko, K-H, Trickett, A, Johnson, P, Elwood, N. Abstract 26 HLA Analysis of the Australian Cord Blood Banks: How Diverse Are Donors?. Stem Cells Translational Medicine 11(Supplement_1) : s31 -s31 2022
    view publication
  • Liu, L, McDonald, T, Elwood, N. Abstract 23 A First Insight into the Validity of Post-Thaw Cell Recovery, Viability, and Potency Over Time. Stem Cells Translational Medicine 11(Supplement_1) : s27 -s28 2022
    view publication
  • Paton, MCB, Wall, DA, Elwood, N, Chiang, K-Y, Cowie, G, Novak, I, Finch-Edmondson, M. Safety of allogeneic umbilical cord blood infusions for the treatment of neurological conditions: a systematic review of clinical studies.. Cytotherapy 24(1) : 2 -9 2022
    view publication

Page 2 of 14